HONOUR held a mid-year 2022 work conference

On August 3-5,  HONOUR Pharmaceutical Equipment Co., Ltd. organized a work summary and analysis meeting in the middle of 2022 on the bank of Qishan Lake. The heads of various business departments and sales representatives participated in the meeting.

The meeting was held in the form of a discussion. Each person in charge reported the completion of the work in the first half of the year and the work objectives in the second half of the year. At the same time, he analyzed the deficiencies and improvement measures in the work, and the general manager commented on them one by one.

The meeting made an in-depth analysis from multiple dimensions such as market, sales, supply chain and execution, and discussed the development layout of the company in the next three to five years, so as to prepare for the upgrading of equipment in the pharmaceutical industry.

       Judging from the completion of the work of the executive department, the construction acceptance of 11 key projects was completed in the first half of the year, and the contract amount accounted for 89.4% of the total amount in 2021. The team Intelligence was brought into play in the projects of Yangzi River shengsen, Shanghai Doning biology, Shanghai mianyi biology and so on, which overcame the difficulties caused by Shanghai city closure,Deliver on schedule; Create new technology design in China, America, East China and other projects, and win the reputation of "Excellent Supplier"; Adhere to the concept of "all-in-one" to overcome difficulties in old customer projects such as Lunan Group, Yiling Pharmaceutical and Ruiyang Pharmaceutical. The key projects in the second half of the year include kelaiying biological project, Shanghai Biological Institute project, kunyao group Preparation Project, etc,At the beginning, we will move forward without changing. We will work hard to create a new pattern and broaden the new channel.

In the first half of the year, HONOUR's qualifications were upgraded, factories were added, and elites gathered, which made preparations for the iteration of the pharmaceutical industry, stable development and innovative and intelligent manufacturing.